文献速递胸部肿瘤放疗姑息放疗与转移瘤

立体定向体部放疗与纳武利尤单抗在转移性非小细胞肺癌患者中诱导的远隔效应报告

Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
PubMed 文献 · Radiat Oncol · 2018-05-31

本文报告一例转移性非小细胞肺癌患者,在接受抗PD-1治疗(纳武利尤单抗)及对部分受累部位行立体定向体部放疗后,出现远隔效应并达到完全缓解。作者认为该病例证实了非小细胞肺癌中存在远隔效应,并提示免疫检查点抑制与局部消融放疗之间存在协同作用,建议在前瞻性临床试验中进一步研究该方案用于寡转移或寡进展非小细胞肺癌。

要点

  • 转移性非小细胞肺癌患者经纳武利尤单抗联合立体定向体部放疗后出现远隔效应并达完全缓解。
  • 作者认为该病例证实非小细胞肺癌中存在远隔效应。
  • 作者建议在前瞻性临床试验中进一步研究该方案用于寡转移或寡进展非小细胞肺癌。

核心结论

  • 作者认为该病例报告证实了非小细胞肺癌中存在远隔效应,并提示免疫检查点抑制与局部消融放疗之间存在协同作用。
  • 作者建议在前瞻性临床试验中进一步研究该方案用于寡转移或寡进展的非小细胞肺癌。

研究设计与样本

  • 本文为个案报告,描述一例转移性非小细胞肺癌患者接受抗PD-1治疗及对部分受累部位行立体定向体部放疗后出现远隔效应。

主要发现

  • 该转移性非小细胞肺癌患者在接受抗PD-1治疗及对部分受累部位行立体定向体部放疗后,因远隔效应而达到完全缓解。

临床怎么用

  • 作者认为该病例提示免疫检查点抑制与局部消融放疗的协同作用值得在前瞻性临床试验中进一步研究,用于寡转移或寡进展的非小细胞肺癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The existence of abscopal effects has been suggested already a long time ago, but only recently with the advent of immune checkpoint inhibition in clinical oncology and modern imaging techniques has it become possible to directly observe such effects in patients. They have been well described in patients with malignant melanoma being treated with immune-checkpoint inhibitors and stereotactic radiotherapy, but experience in other malignancies is very limited. CASE PRESENTATION: Here, we describe a case of a patient with metastatic non-small cell lung cancer, who experienced a complete response secondary to an abscopal effect on treatment with anti-PD-1 therapy and stereotactic body radiotherapy to some of the involved sites. CONCLUSIONS: Our case reports confirms the existence of abscopal effects in NSCLC and suggests synergism between immune-checkpoint inhibition and local ablative RT. We suggest that this approach is now further studied in prospective clinical trials on oligo-metastatic or oligo-progressing NSCLC.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Britschgi C, Riesterer O, Burger IA, et al. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer. Radiat Oncol. 2018. PMID: 29855323. doi:10.1186/s13014-018-1049-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。